Wait, we have a special offer for you! ✋

Get your exclusive discount now

YES, get the discount! No, I'd pay the full price

G-CSF (Granulocyte Colony Stimulating Factors) Market 2021 - By Type (Pegfilgrastim, Filgrastim, Lenograstim), By Application (Oncology, Blood Disorders, Chronic and Autoimmune Disorders), And By Region, Opportunities And Strategies – Global Forecast To 2030

G-CSF (Granulocyte Colony Stimulating Factors) Market - By Type (Pegfilgrastim, Filgrastim, Lenograstim, Others), By Application (Oncology, Blood Disorders, Chronic and Autoimmune Disorders, Others), And By Region, Opportunities And Strategies – Global Forecast To 2030

Starting Price : $4000.00 $2800.00 | Pages : 270 | Published : February 2021 | | Format : pdf

Purchase Options
Request a Sample
Request For Discount
Customise Your Report
Item added to cart!
Request For Proposal
Request For Regional Data
FAQs

Need assistance or more information before the purchase?

Enquire Before Buying

Proud Members Of

checkslacipN checkaoirsN checkscipN
Description Table Of Contents Tables & Figures Market Insights Related Reports

G-CSF (Granulocyte Colony Stimulating Factors) Market Definition

The G-CSF (Granulocyte Colony Stimulating Factors) market consists of sales of G-CSF drugs and related services. G-CSF, granulocyte-colony stimulating factor, based drugs stimulates the bone marrow to produce granulocytes and stem cells and release them into the bloodstream. G-CSF also stimulates the survival, proliferation, differentiation, and function of neutrophil precursors and mature neutrophils through signal transduction pathways.

Book your 30 minutes free consultation with our research experts

Contact Us

G-CSF (Granulocyte Colony Stimulating Factors) Market Size

The global G-CSF market reached a value of nearly $5,005.6 million in 2020, having decreased at a compound annual growth rate (CAGR) of -5.3% since 2015, primarily due to high uptake of biosimilars in the EU and USA and COVID impact. The market is expected to grow from $5,005.6 million in 2020 to $5,721.6 million in 2025 at a rate of 2.7%. The global granulocyte colony stimulating factors market is then expected to grow at a CAGR of 6.3% from 2025 and reach $7,761.1 million in 2030.

Growth in the historic period resulted from increase in cancer prevalence, strong economic growth in emerging markets, increased healthcare expenditure, increase in pharmaceutical R&D expenditure and government initiatives. Factor that negatively affected growth in the historic period was pricing pressures from regulators, challenges due to regulatory changes and low healthcare access.

Going forward, increasing prevalence of cancer, increasing demand for prophylaxis granulocyte colony-stimulating factor (G-CSF), rise in healthcare expenditure, high potential of emerging economies, technology advances and high penetration of the biosimilar drugs will drive the growth of the global granulocyte colony stimulating factors market. Factors that could hinder the growth of the global granulocyte colony stimulating factors market in the future include high costs of drugs, rise in interest rates, high cost of drug development with threat of failure and coronavirus pandemic.

Granulocyte Colony Stimulating Factors Market Drivers

The key drivers of the G-CSF market include:

Increasing Demand For Prophylaxis Granulocyte Colony-Stimulating Factor (G-CSF)

The increasing demand for prophylaxis granulocyte colony-stimulating factor (G-CSF) is another key factor driving the growth of the G-CSF market. The prophylaxis with G-CSF decreases the occurrence of febrile neutropenia (FN), allowing patients to receive and stay on myelosuppressive chemotherapy. The current use of G-CSF prophylaxis offers significant benefits including reducing incidents of febrile neutropenia by 3.3 million and cases of chemotherapy reduced dosage intensity by less than 85%, over the next 10 years. Therefore, the increasing demand for prophylaxis granulocyte colony-stimulating factor (G-CSF) is expected to drive the growth of the G-CSF market.

Granulocyte Colony Stimulating Factors Market Restraints

The key restraints on the global granulocyte colony stimulating factors market include:

High Costs Of Drugs

The high cost is a key factor limiting the growth of the G-CSF market. Improved chemotherapy administration is responsible for the rise in instant medical expenses in breast cancer patients receiving primary prophylactic (PP) G-CSF. According to a study conducted by the American Journal of Managed Care, PPG-CSF administration in the first chemotherapy class was associated with a 57 % increase in total Medicare costs during the study period, despite a fall in medical costs for neutropenia. Around 42% of the increase can be attributed to the rise in the costs of chemotherapy. Each shot of PPG-CSF costs more than $250. Therefore, the high cost is expected to hinder the growth of the G-CSF (Granulocyte Colony Stimulating Factors) market.

G-CSF (Granulocyte Colony Stimulating Factors) Market Trends

Major trends influencing the G-CSF market include:

Robust Research & Development

The G-CSF market is witnessing robust research and development activities. These research and development activities have led to increasing success rates in clinical trials. Research and development is being carried out by market leaders in the Granolocyte Colony Stimulating Factors market as they continuously strive to make breakthroughs in the market in the form of new and effective drugs. For instance, as of October 2020, Spectrum Pharmaceuticals, a biopharmaceutical company focused on novel and targeted oncology therapies is anticipating FDA approval for a Biologics License Application (BLA) for ROLONTIS, a novel, long-acting granulocyte colony-stimulating factor (G-CSF), an indication for the treatment of neutropenia in patients receiving myelosuppressive anti-cancer drugs. Also, many drugs are in pipeline under development by some of the major companies such as Amgen, Biocon.

Large Number Of Strategic Partnerships In The Global Granulocyte Colony Stimulating Factors Market

Companies in the Granolocyte Colony Stimulating Factors market are increasing their product innovation through strategic collaborations. To sustain in the increasingly competitive market, companies are developing innovative products as well as sharing skills and expertise with other companies. While companies have long collaborated with each other as well as with academic and research institutions in this market by way of partnerships, in or out-licensing deals, this trend has been increasing over recent years. For instance, in September 2020, Humanigen, Inc., a clinical stage biopharmaceutical company collaborated with Lonza and Catalent to expand manufacturing of COVID-19 therapeutic candidate Lenzilumab. Lenzilumab is the patented Humaneered® anti-human granulocyte macrophage-colony stimulating factor (GM-CSF) monoclonal antibody with the potential to prevent and treat cytokine storm, which is believed to cause the acute respiratory distress syndrome in severe COVID-19 cases.

Opportunities And Recommendations In The Granulocyte Colony Stimulating Factors Market

Opportunities – The top opportunities in the global granulocyte colony stimulating factors market segmented by type will arise in the pegfilgrastim segment, which will gain $420.6 million of global annual sales by 2025. The top opportunities in segment by application will arise in the oncology segment, which will gain $539.6 million of global annual sales by 2025. The G-CSF (Granulocyte Colony Stimulating Factors) market size will gain the most in the USA at $337.0 million.

Recommendations – To take advantage of the opportunities, The Business Research Company recommends the G-CSF  market companies to focus on research and development, acquisitions of other companies, expand in emerging markets, offering skimmed pricing, leveraging social media platforms, targeting hospitals and pharmacies to spread awareness and target geriatric populations.

The countries covered in Granulocyte Colony Stimulating Factors Market are China, Japan, India, Australia, Indonesia, South Korea, USA, Brazil, UK, Germany, France, Russia

G-CSF (Granulocyte Colony Stimulating Factors) Market Segmentation

The G-CSF (Granulocyte Colony Stimulating Factors) market is segmented by type, by application, and by geography.
By Type -
The G-CSF (Granulocyte Colony Stimulating Factors) market is segmented by type
    • a) Pegfilgrastim
    • b) Filgrastim
    • c) Lenograstim
    • d) Others
The pegfilgrastim market was the largest segment of the G-CSF (Granulocyte Colony Stimulating Factors) market segmented by type, accounting for 77.6% of the total in 2020. Going forward, the filgrastim segment is expected to be the fastest growing segment in the G-CSF (Granulocyte Colony Stimulating Factors) market segmented by type, at a CAGR of 5.7% during 2020-2025.
By Application-
The Granulocyte Colony Stimulating Factors market is segmented by application
    • a) Oncology
    • b) Blood Disorders
    • c) Chronic and Autoimmune Disorders
    • d) Others
The oncology market was the largest segment of the G-CSF (Granulocyte Colony Stimulating Factors) market segmented by application, accounting for 61.7% of the total in 2020. Going forward, the oncology segment is expected to be the fastest growing segment in the G-CSF (Granulocyte Colony Stimulating Factors) market segmented by application, at a CAGR of 3.3% during 2020-2025.
By Geography - The G-CSF (Granulocyte Colony Stimulating Factors) market is segmented into
    • o North America
      • • USA
      • o Western Europe
      • • UK
      • • Germany
      • • France
      o Asia Pacific
      • • China
      • • India
      • • Japan
      • • Australia
      • • Indonesia
      • • South Korea
      o Eastern Europe
      • • Russia
      o South America
      • • Brazil
      o Middle East
      o Africa
North America was the largest region in the global G-CSF (Granulocyte Colony Stimulating Factors) market, accounting for 50.1% of the total in 2020. It was followed by Western Europe, and then the other regions. Going forward, the fastest-growing regions in the G-CSF (Granulocyte Colony Stimulating Factors) market will be Middle East, and Eastern Europe, where growth will be at CAGRs of 25.9% and 11.7% respectively. These will be followed by South America, and Africa where the markets are expected to grow at CAGRs of 8.6% and 5.0% respectively.

G-CSF (Granulocyte Colony Stimulating Factors) Competitive Landscape

Major Competitors In The Global Granulocyte Colony Stimulating Factors Market are:

  • Amgen Inc.
  • Coherus Biosciences Inc.
  • Sandoz (Novartis)
  • Biocon/Mylan
  • Teva Pharmaceutcals Inc.

    • Other Competitors In The Global Granulocyte Colony Stimulating Factors Market Include:

  • Chugai Pharma
  • Intalfarmaco Group
  • Pfizer
  • Sun Pharmaceutical Industries Limited
  • BeyondSpring Inc.
  • Kyowa Hakko Kirin Co. Ltd
  • BioCad
  • Intas Pharmaceuticals
  • Novartis AG
  • Stada Arzneimittel
  • Dong-A Socio Group
  • Dr. Reddy`s Laboratories
  • Celltrion Inc.
  • Emcure Pharmaceuticals
  • Accord Healthcare UK
  • Spectrum Pharmaceuticals
  • Apobiologix
  • Apotex Inc.
  • Eurofarma Laboratórios
  • BIOPHARMA-MEA
  • NeoTX
  • AID Genomics Limited
  • GlaxoSmithKline plc
  • AstraZeneca
  • Julphar
  • Novo Nordisk A/S
  • Kitov Pharma Limited
  • CureTech Ltd.
  • Neopharma

      • Table Of Contents

      1. G-CSF (Granulocyte Colony Stimulating Factors) Market Executive Summary

      2. Table of Contents

      3. List of Figures

      4. List of Tables

      5. Report Structure

      6. Introduction

      6.1. Segmentation By Geography

      6.2. Segmentation By Type

      6.3. Segmentation By Application

      7. G-CSF (Granolocyte Colony Stimulating Factors) Market Characteristics

      7.1. Market Definition

      7.2. Segmentation By Type

      7.2.1. Pegfilgrastim

      7.2.2. Filgrastim

      7.2.3. Lenograstim

      7.2.4. Others

      7.3. Segmentation By Application

      7.3.1. Oncology

      7.3.2. Blood Disorders

      7.3.3. Chronic and Autoimmune Disorders

      7.3.4. Others

      8. G-CSF (Granulocyte Colony Stimulating Factors) Market Trends And Strategies

      8.1. Robust Research & Development

      8.2. Growing Mergers And Acquisitions

      8.3. Large Number Of Strategic Partnerships

      8.4. Demand For Biosimilars In The Treatment Of Neutropenia

      9. Impact Of COVID-19 On The G-CSF (Granolocyte Colony Stimulating Factors) Market

      9.1. Clinical Trial Delays

      9.2. Impact On Major G-CSF Companies In The Market

      10. Global G-CSF (Granulocyte Colony Stimulating Factors) Market Size And Growth

      10.1. Market Size

      10.2. Historic Market Growth, 2015 – 2020, Value ($ Million)

      10.2.1. Drivers Of The Market 2015 – 2020

      10.2.2. Restraints On The Market 2015 – 2020

      10.3. Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

      10.3.1. Drivers Of The Market 2020 – 2025

      10.3.2. Restraints On The Market 2020 – 2025

      11. Global G-CSF (Granulocyte Colony Stimulating Factors) Market Segmentation

      11.1. Global G-CSF (Granulocyte Colony Stimulating Factors) Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      11.1.1. Pegfilgrastim

      11.1.2. Filgrastim

      11.1.3. Others

      11.1.4. Lenograstim

      11.2. Global G-CSF (Granulocyte Colony Stimulating Factors) Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      11.2.1. Oncology

      11.2.2. Chronic And Autoimmune Diseases

      11.2.3. Blood Disorders

      11.2.4. Other Applications

      12. G-CSF (Granulocyte Colony Stimulating Factors) Market, Regional And Country Analysis

      12.1. Global G-CSF (Granulocyte Colony Stimulating Factors) Market, By Region, Historic and Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      12.2. Global G-CSF (Granulocyte Colony Stimulating Factors) Market, By Country, Historic and Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      13. Asia-Pacific G-CSF (Granulocyte Colony Stimulating Factors) Market

      13.1. Asia-Pacific G-CSF (Granulocyte Colony Stimulating Factors) Market Overview

      13.1.1. Region Information

      13.1.2. Impact Of COVID-19

      13.1.3. Market Information

      13.1.4. Background Information

      13.1.5. Government Initiatives

      13.1.6. Regulations

      13.1.7. Regulatory Bodies

      13.1.8. Major Associations

      13.1.9. Taxes levied

      13.1.10. Corporate Tax Structure

      13.1.11. Investments

      13.1.12. Major Companies

      13.2. Asia-Pacific G-CSF (Granulocyte Colony Stimulating Factors) Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      13.3. Asia-Pacific G-CSF (Granulocyte Colony Stimulating Factors) Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

      13.4. Asia-Pacific G-CSF (Granulocyte Colony Stimulating Factors) Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      13.5. Asia-Pacific G-CSF (Granulocyte Colony Stimulating Factors) Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      13.6. Asia-Pacific G-CSF (Granulocyte Colony Stimulating Factors) Market: Country Analysis

      13.7. China G-CSF (Granulocyte Colony Stimulating Factors) Market

      13.8. China G-CSF (Granulocyte Colony Stimulating Factors) Market Overview

      13.8.1. Country Information

      13.8.2. Impact Of COVID-19

      13.8.3. Market Information

      13.8.4. Background Information

      13.8.5. Government Initiatives

      13.8.6. Regulations

      13.8.7. Regulatory Bodies

      13.8.8. Major Associations

      13.8.9. Taxes levied

      13.8.10. Corporate Tax Structure

      13.8.11. Investments

      13.8.12. Major Companies

      13.9. China G-CSF (Granulocyte Colony Stimulating Factors) Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      13.10. China G-CSF (Granulocyte Colony Stimulating Factors) Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

      13.11. China G-CSF (Granulocyte Colony Stimulating Factors) Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      13.12. China G-CSF (Granulocyte Colony Stimulating Factors) Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      13.13. India G-CSF (Granulocyte Colony Stimulating Factors) Market

      13.14. India G-CSF (Granulocyte Colony Stimulating Factors) Market Overview

      13.14.1. Country Information

      13.14.2. Impact Of COVID-19

      13.14.3. Market Information

      13.14.4. Background Information

      13.14.5. Government Initiatives

      13.14.6. Regulations

      13.14.7. Regulatory Bodies

      13.14.8. Major Associations

      13.14.9. Taxes levied

      13.14.10. Corporate Tax Structure

      13.14.11. Investments

      13.14.12. Major Companies

      13.15. India G-CSF (Granulocyte Colony Stimulating Factors) Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      13.16. India G-CSF (Granulocyte Colony Stimulating Factors) Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

      13.17. India G-CSF (Granulocyte Colony Stimulating Factors) Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      13.18. India G-CSF (Granulocyte Colony Stimulating Factors) Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      13.19. Japan G-CSF (Granulocyte Colony Stimulating Factors) Market

      13.20. Japan G-CSF (Granulocyte Colony Stimulating Factors) Market Overview

      13.20.1. Country Information

      13.20.2. Impact Of COVID-19

      13.20.3. Market Information

      13.20.4. Background Information

      13.20.5. Government Initiatives

      13.20.6. Regulations

      13.20.7. Regulatory Bodies

      13.20.8. Major Associations

      13.20.9. Corporate Tax Structure

      13.20.10. Investments

      13.20.11. Major Companies

      13.21. Japan G-CSF (Granulocyte Colony Stimulating Factors) Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      13.22. Japan G-CSF (Granulocyte Colony Stimulating Factors) Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

      13.23. Japan G-CSF (Granulocyte Colony Stimulating Factors) Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      13.24. Japan G-CSF (Granulocyte Colony Stimulating Factors) Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      13.25. Australia G-CSF (Granulocyte Colony Stimulating Factors) Market

      13.26. Australia G-CSF (Granulocyte Colony Stimulating Factors) Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      13.27. Australia G-CSF (Granulocyte Colony Stimulating Factors) Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

      13.28. Australia G-CSF (Granulocyte Colony Stimulating Factors) Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      13.29. Australia G-CSF (Granulocyte Colony Stimulating Factors) Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      13.30. Indonesia G-CSF (Granulocyte Colony Stimulating Factors) Market

      13.31. Indonesia G-CSF (Granulocyte Colony Stimulating Factors) Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      13.32. Indonesia G-CSF (Granulocyte Colony Stimulating Factors) Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

      13.33. Indonesia G-CSF (Granulocyte Colony Stimulating Factors) Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      13.34. Indonesia G-CSF (Granulocyte Colony Stimulating Factors) Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      13.35. South Korea G-CSF (Granulocyte Colony Stimulating Factors) Market

      13.36. South Korea G-CSF (Granulocyte Colony Stimulating Factors) Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      13.37. South Korea G-CSF (Granulocyte Colony Stimulating Factors) Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

      13.38. South Korea G-CSF (Granulocyte Colony Stimulating Factors) Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      13.39. South Korea G-CSF (Granulocyte Colony Stimulating Factors) Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      14. Western Europe G-CSF (Granulocyte Colony Stimulating Factors) Market

      14.1. Western Europe G-CSF (Granulocyte Colony Stimulating Factors) Market Overview

      14.1.1. Region Information

      14.1.2. Impact Of COVID-19

      14.1.3. Market Information

      14.1.4. Background Information

      14.1.5. Government Initiatives

      14.1.6. Regulations

      14.1.7. Regulatory Bodies

      14.1.8. Major Associations

      14.1.9. Taxes Levied

      14.1.10. Corporate Tax Structure

      14.1.11. Investments

      14.1.12. Major Companies

      14.2. Western Europe G-CSF (Granulocyte Colony Stimulating Factors) Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      14.3. Western Europe G-CSF (Granulocyte Colony Stimulating Factors) Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

      14.4. Western Europe G-CSF (Granulocyte Colony Stimulating Factors) Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      14.5. Western Europe G-CSF (Granulocyte Colony Stimulating Factors) Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      14.6. Western Europe G-CSF (Granulocyte Colony Stimulating Factors) Market: Country Analysis

      14.7. UK G-CSF (Granulocyte Colony Stimulating Factors) Market

      14.8. UK G-CSF (Granulocyte Colony Stimulating Factors) Market Overview

      14.8.1. Country Information

      14.8.2. Impact Of COVID-19

      14.8.3. Market Information

      14.8.4. Background Information

      14.8.5. Government Initiatives

      14.8.6. Regulations

      14.8.7. Regulatory Bodies

      14.8.8. Major Associations

      14.8.9. Taxes Levied

      14.8.10. Corporate Tax Structure

      14.8.11. Investments

      14.8.12. Major Companies

      14.9. UK G-CSF (Granulocyte Colony Stimulating Factors) Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      14.10. UK G-CSF (Granulocyte Colony Stimulating Factors) Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

      14.11. UK G-CSF (Granulocyte Colony Stimulating Factors) Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      14.12. UK G-CSF (Granulocyte Colony Stimulating Factors) Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      14.13. Germany G-CSF (Granulocyte Colony Stimulating Factors) Market

      14.14. Germany G-CSF (Granulocyte Colony Stimulating Factors) Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      14.15. Germany G-CSF (Granulocyte Colony Stimulating Factors) Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

      14.16. Germany G-CSF (Granulocyte Colony Stimulating Factors) Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      14.17. Germany G-CSF (Granulocyte Colony Stimulating Factors) Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      14.18. France G-CSF (Granulocyte Colony Stimulating Factors) Market

      14.19. France G-CSF (Granulocyte Colony Stimulating Factors) Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      14.20. France G-CSF (Granulocyte Colony Stimulating Factors) Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

      14.21. France G-CSF (Granulocyte Colony Stimulating Factors) Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      14.22. France G-CSF (Granulocyte Colony Stimulating Factors) Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      15. Eastern Europe G-CSF (Granulocyte Colony Stimulating Factors) Market

      15.1. Eastern Europe G-CSF (Granulocyte Colony Stimulating Factors) Market Overview

      15.1.1. Region Information

      15.1.2. Impact Of COVID-19

      15.1.3. Market Information

      15.1.4. Background Information

      15.1.5. Government Initiatives

      15.1.6. Regulations

      15.1.7. Regulatory Bodies

      15.1.8. Major Associations

      15.1.9. Taxes Levied

      15.1.10. Corporate Tax Structure

      15.1.11. Investments

      15.1.12. Major Companies

      15.2. Eastern Europe G-CSF (Granulocyte Colony Stimulating Factors) Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      15.3. Eastern Europe G-CSF (Granulocyte Colony Stimulating Factors) Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

      15.4. Eastern Europe G-CSF (Granulocyte Colony Stimulating Factors) Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      15.5. Eastern Europe G-CSF (Granulocyte Colony Stimulating Factors) Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      15.6. Eastern Europe G-CSF (Granulocyte Colony Stimulating Factors) Market: Country Analysis

      15.7. Russia G-CSF (Granulocyte Colony Stimulating Factors) Market

      15.8. Russia G-CSF (Granulocyte Colony Stimulating Factors) Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      15.9. Russia G-CSF (Granulocyte Colony Stimulating Factors) Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

      15.10. Russia G-CSF (Granulocyte Colony Stimulating Factors) Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      15.11. Russia G-CSF (Granulocyte Colony Stimulating Factors) Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      16. North America G-CSF (Granulocyte Colony Stimulating Factors) Market

      16.1. North America G-CSF (Granulocyte Colony Stimulating Factors) Market Overview

      16.1.1. Region Information

      16.1.2. Impact Of COVID-19

      16.1.3. Market Information

      16.1.4. Background Information

      16.1.5. Government Initiatives

      16.1.6. Regulations

      16.1.7. Regulatory Bodies

      16.1.8. Major Associations

      16.1.9. Taxes Levied

      16.1.10. Corporate Tax Structure

      16.1.11. Investments

      16.1.12. Major Companies

      16.2. North America G-CSF (Granulocyte Colony Stimulating Factors) Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      16.3. North America G-CSF (Granulocyte Colony Stimulating Factors) Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

      16.4. North America G-CSF (Granulocyte Colony Stimulating Factors) Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      16.5. North America G-CSF (Granulocyte Colony Stimulating Factors) Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      16.6. North America G-CSF (Granulocyte Colony Stimulating Factors) Market: Country Analysis

      16.7. USA G-CSF (Granulocyte Colony Stimulating Factors) Market

      16.8. USA G-CSF (Granulocyte Colony Stimulating Factors) Market Overview

      16.8.1. Country Information

      16.8.2. Impact Of COVID-19

      16.8.3. Market Information

      16.8.4. Background Information

      16.8.5. Government Initiatives

      16.8.6. Regulations

      16.8.7. Regulatory Bodies

      16.8.8. Major Associations

      16.8.9. Taxes Levied

      16.8.10. Corporate Tax Structure

      16.8.11. Investments

      16.8.12. Major Companies

      16.9. USA G-CSF (Granulocyte Colony Stimulating Factors) Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      16.10. USA G-CSF (Granulocyte Colony Stimulating Factors) Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

      16.11. USA G-CSF (Granulocyte Colony Stimulating Factors) Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      16.12. USA G-CSF (Granulocyte Colony Stimulating Factors) Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      17. South America G-CSF (Granulocyte Colony Stimulating Factors) Market

      17.1. South America G-CSF (Granulocyte Colony Stimulating Factors) Market Overview

      17.1.1. Region Information

      17.1.2. Impact Of COVID-19

      17.1.3. Market Information

      17.1.4. Background Information

      17.1.5. Government Initiatives

      17.1.6. Regulations

      17.1.7. Regulatory Bodies

      17.1.8. Major Associations

      17.1.9. Taxes Levied

      17.1.10. Corporate Tax Structure

      17.1.11. Investments

      17.1.12. Major Companies

      17.2. South America G-CSF (Granulocyte Colony Stimulating Factors) Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      17.3. South America G-CSF (Granulocyte Colony Stimulating Factors) Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

      17.4. South America G-CSF (Granulocyte Colony Stimulating Factors) Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      17.5. South America G-CSF (Granulocyte Colony Stimulating Factors) Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      17.6. South America G-CSF (Granulocyte Colony Stimulating Factors) Market: Country Analysis

      17.7. Brazil G-CSF (Granulocyte Colony Stimulating Factors) Market

      17.8. Brazil G-CSF (Granulocyte Colony Stimulating Factors) Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      17.9. Brazil G-CSF (Granulocyte Colony Stimulating Factors) Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

      17.10. Brazil G-CSF (Granulocyte Colony Stimulating Factors) Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      17.11. Brazil G-CSF (Granulocyte Colony Stimulating Factors) Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      18. Middle East G-CSF (Granulocyte Colony Stimulating Factors) Market

      18.1. Middle East G-CSF (Granulocyte Colony Stimulating Factors) Market Overview

      18.1.1. Region information

      18.1.2. Impact Of COVID- 19

      18.1.3. Market information

      18.1.4. Background information

      18.1.5. Government initiatives

      18.1.6. Regulations

      18.1.7. Regulatory bodies

      18.1.8. Major Associations

      18.1.9. Taxes Levied

      18.1.10. Corporate Tax Structure

      18.1.11. Investments

      18.1.12. Major companies

      18.2. Middle East G-CSF (Granulocyte Colony Stimulating Factors) Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      18.3. Middle East G-CSF (Granulocyte Colony Stimulating Factors) Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

      18.4. Middle East G-CSF (Granulocyte Colony Stimulating Factors) Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      18.5. Middle East G-CSF (Granulocyte Colony Stimulating Factors) Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      19. Africa G-CSF (Granulocyte Colony Stimulating Factors) Market

      19.1. Africa G-CSF (Granulocyte Colony Stimulating Factors) Market Overview

      19.1.1. Region information

      19.1.2. Impact Of COVID-19

      19.1.3. Market information

      19.1.4. Background information

      19.1.5. Government initiatives

      19.1.6. Regulations

      19.1.7. Regulatory bodies

      19.1.8. Associations

      19.1.9. Taxes Levied

      19.1.10. Corporate Tax Structure

      19.1.11. Investments

      19.1.12. Major companies

      19.2. Africa G-CSF (Granulocyte Colony Stimulating Factors) Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      19.3. Africa G-CSF (Granulocyte Colony Stimulating Factors) Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

      19.4. Africa G-CSF (Granulocyte Colony Stimulating Factors) Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      19.5. Africa G-CSF (Granulocyte Colony Stimulating Factors) Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      20. Global G-CSF (Granulocyte Colony Stimulating Factors) Market Competitive Landscape

      20.1. Company Profiles

      20.2. Amgen Inc.

      20.2.1. Company Overview

      20.2.2. Products And Services

      20.2.3. Business Strategy

      20.2.4. Financial Overview

      20.3. Coherus Biosciences Inc.

      20.3.1. Company Overview

      20.3.2. Products And Services

      20.3.3. Business Strategy

      20.3.4. Financial Overview

      20.4. Sandoz (Novartis)

      20.4.1. Company Overview

      20.4.2. Products And Services

      20.4.3. Business Strategy

      20.4.4. Financial overview

      20.5. Biocon

      20.5.1. Company Overview

      20.5.2. Products And Services

      20.5.3. Business Strategy

      20.5.4. Financial Overview

      20.6. Mylan

      20.6.1. Company Overview

      20.6.2. Products And Services

      20.6.3. Business Strategy

      20.6.4. Financial Overview

      20.7. Teva Pharmaceuticals

      20.7.1. Company Overview

      20.7.2. Products And Services

      20.7.3. Business Strategy

      20.7.4. Financial Overview

      21. Key Mergers And Acquisitions In The G-CSF (Granulocyte Colony Stimulating Factors) Market

      21.1. ChrysCapital Acquired Stakes In Intas Pharmaceuticals

      21.2. Celltrion Acquired Takeda APAC Assets

      21.3. Amgen Acquired Japanese JV with Astellas

      21.4. True North Acquired Stake In Biocon Biologics Ltd.

      21.5. PAG Acquired Hisun BioRay Bio-pharmaceutical Co., Ltd.

      21.6. Pfizer Inc. Acquired Array BioPharma Inc.

      21.7. Fuji Pharma Co., Ltd. Acquired Stake In Alvotech

      21.8. Kashiv Pharma Acquired Adello Biologics

      21.9. Bristol-Myers Squibb Acquired Celgene Corporation

      21.10. Takeda Pharmaceutical Company Limited Acquired Shire Plc

      21.11. Sun Pharmaceutical Industries Limited Acquired Zenotech Laboratories

      22. G-CSF (Granulocyte Colony Stimulating Factors) Market Opportunities And Strategies

      22.1. Global G-CSF (Granulocyte Colony Stimulating Factors) Market In 2025 – Countries Offering Most New Opportunities

      22.2. Global G-CSF (Granulocyte Colony Stimulating Factors) Market In 2025 – Segments Offering Most New Opportunities

      22.3. Global G-CSF (Granulocyte Colony Stimulating Factors) Market In 2025 – Growth Strategies

      22.3.1. Market Trend Based Strategies

      22.3.2. Competitor Strategies

      23. G-CSF (Granulocyte Colony Stimulating Factors) Market, Conclusions And Recommendations

      23.1. Conclusions

      23.2. Recommendations

      23.2.1. Product

      23.2.2. Place

      23.2.3. Price

      23.2.4. Promotion

      23.2.5. People

      24. Appendix

      24.1. Market Data Sources

      24.2. Research Methodology

      24.3. Currencies

      24.4. Research Inquiries

      24.5. The Business Research Company

      24.6. Copyright and Disclaimer

    List Of Tables

      Table 1: Global G-CSF (Granulocyte Colony Stimulating Factors) Market, Historic, 2015 – 2020, $ Million
    • Table 2: Global G-CSF (Granulocyte Colony Stimulating Factors) Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 3: Global G-CSF (Granulocyte Colony Stimulating Factors) Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 4: Global G-CSF (Granulocyte Colony Stimulating Factors) Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 5: Global G-CSF (Granulocyte Colony Stimulating Factors) Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 6: Global G-CSF (Granulocyte Colony Stimulating Factors) Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 7: Global G-CSF (Granulocyte Colony Stimulating Factors) Market, By Region, Historic and Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 8: Global G-CSF (Granulocyte Colony Stimulating Factors) Market, By Region, Historic and Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 9: Global G-CSF (Granulocyte Colony Stimulating Factors) Market, By Country, Historic and Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 10: Global G-CSF (Granulocyte Colony Stimulating Factors) Market, By Country, Historic and Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 11: Asia Pacific GDP Per Capita, 2015-2020, $
    • Table 12: Asia Pacific G-CSF Market, Population By Age Group, By Country, 2015-2023, Thousands
    • Table 13: Asia-Pacific, Per Capita Healthcare Expenditure, By Country, 2015-2019, $
    • Table 14: Asia Pacific Cancer Prevalence, Estimated Average Expenditure, 2019, $
    • Table 15: Asia-Pacific G-CSF Market, Healthcare Services Market Size, By Country, 2015-2025, $ Billion
    • Table 16: Asia-Pacific G-CSF (Granulocyte Colony Stimulating Factors) Market, Historic, 2015 – 2020, $ Million
    • Table 17: Asia-Pacific G-CSF (Granulocyte Colony Stimulating Factors) Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 18: Asia-Pacific G-CSF (Granulocyte Colony Stimulating Factors) Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 19: Asia-Pacific G-CSF (Granulocyte Colony Stimulating Factors) Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 20: Asia-Pacific G-CSF (Granulocyte Colony Stimulating Factors) Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 21: Asia-Pacific G-CSF (Granulocyte Colony Stimulating Factors) Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 22: China GDP Per Capita, 2015-2020, $
    • Table 23: China G-CSF Market, Population By Age Group, 2015-2023, Thousands
    • Table 24: China Per Capita Healthcare Expenditure, 2015-2019, $
    • Table 25: China Cancer Prevalence, Estimated Average Expenditure, 2019, $
    • Table 26: China G-CSF Market, Healthcare Services Market Size, By Country, 2015-2025, $ Billion
    • Table 27: China G-CSF (Granulocyte Colony Stimulating Factors) Market, Historic, 2015 – 2020, $ Million
    • Table 28: China G-CSF (Granulocyte Colony Stimulating Factors) Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 29: China G-CSF (Granulocyte Colony Stimulating Factors) Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 30: China G-CSF (Granulocyte Colony Stimulating Factors) Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 31: China G-CSF (Granulocyte Colony Stimulating Factors) Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 32: China G-CSF (Granulocyte Colony Stimulating Factors) Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 33: India GDP Per Capita, 2015-2020, $
    • Table 34: India G-CSF Market, Population By Age Group, 2015-2023, Thousands
    • Table 35: India, Per Capita Healthcare Expenditure, 2015-2019, $
    • Table 36: India Cancer Prevalence, Estimated Average Expenditure, 2019, $
    • Table 37: India G-CSF Market, Healthcare Services Market Size, By Country, 2015-2025, $ Billion
    • Table 38: India G-CSF (Granulocyte Colony Stimulating Factors) Market, Historic, 2015 – 2020, $ Million
    • Table 39: India G-CSF (Granulocyte Colony Stimulating Factors) Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 40: India G-CSF (Granulocyte Colony Stimulating Factors) Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 41: India G-CSF (Granulocyte Colony Stimulating Factors) Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 42: India G-CSF (Granulocyte Colony Stimulating Factors) Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 43: India G-CSF (Granulocyte Colony Stimulating Factors) Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 44: Japan GDP Per Capita, 2015-2020, $
    • Table 45: Japan G-CSF Market, Population By Age Group, 2015-2023, Thousands
    • Table 46: Japan, Per Capita Healthcare Expenditure, 2015-2019, $
    • Table 47: Japan Cancer Prevalence, Estimated Average Expenditure, 2019, $
    • Table 48: Japan G-CSF Market, Healthcare Services Market Size, By Country, 2015-2025, $ Billion
    • Table 49: Japan G-CSF (Granulocyte Colony Stimulating Factors) Market, Historic, 2015 – 2020, $ Million
    • Table 50: Japan G-CSF (Granulocyte Colony Stimulating Factors) Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 51: Japan G-CSF (Granulocyte Colony Stimulating Factors) Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 52: Japan G-CSF (Granulocyte Colony Stimulating Factors) Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 53: Japan G-CSF (Granulocyte Colony Stimulating Factors) Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 54: Japan G-CSF (Granulocyte Colony Stimulating Factors) Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 55: Australia G-CSF (Granulocyte Colony Stimulating Factors) Market, Historic, 2015 – 2020, $ Million
    • Table 56: Australia G-CSF (Granulocyte Colony Stimulating Factors) Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 57: Australia G-CSF (Granulocyte Colony Stimulating Factors) Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 58: Australia G-CSF (Granulocyte Colony Stimulating Factors) Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 59: Australia G-CSF (Granulocyte Colony Stimulating Factors) Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 60: Australia G-CSF (Granulocyte Colony Stimulating Factors) Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 61: Indonesia G-CSF (Granulocyte Colony Stimulating Factors) Market, Historic, 2015 – 2020, $ Million
    • Table 62: Indonesia G-CSF (Granulocyte Colony Stimulating Factors) Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 63: Indonesia G-CSF (Granulocyte Colony Stimulating Factors) Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 64: Indonesia G-CSF (Granulocyte Colony Stimulating Factors) Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 65: Indonesia G-CSF (Granulocyte Colony Stimulating Factors) Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 66: Indonesia G-CSF (Granulocyte Colony Stimulating Factors) Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 67: South Korea G-CSF (Granulocyte Colony Stimulating Factors) Market, Historic, 2015 – 2020, $ Million
    • Table 68: South Korea G-CSF (Granulocyte Colony Stimulating Factors) Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 69: South Korea G-CSF (Granulocyte Colony Stimulating Factors) Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 70: South Korea G-CSF (Granulocyte Colony Stimulating Factors) Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 71: South Korea G-CSF (Granulocyte Colony Stimulating Factors) Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 72: South Korea G-CSF (Granulocyte Colony Stimulating Factors) Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 73: Western Europe GDP Per Capita, 2015-2020, $
    • Table 74: Western Europe G-CSF Market, Population By Age Group, By Country, 2015-2023, Thousands
    • Table 75: Western Europe, Per Capita Healthcare Expenditure, By Country, 2015-2019, $
    • Table 76: Western Europe Estimated Average Expenditure, Cancer Prevalence, 2019
    • Table 77: Western Europe G-CSF Market, Healthcare Services Market Size, By Country, 2015-2025, $ Billion
    • Table 78: Western Europe G-CSF (Granulocyte Colony Stimulating Factors) Market, Historic, 2015 – 2020, $ Million
    • Table 79: Western Europe G-CSF (Granulocyte Colony Stimulating Factors) Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 80: Western Europe G-CSF (Granulocyte Colony Stimulating Factors) Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 81: Western Europe G-CSF (Granulocyte Colony Stimulating Factors) Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 82: Western Europe G-CSF (Granulocyte Colony Stimulating Factors) Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 83: Western Europe G-CSF (Granulocyte Colony Stimulating Factors) Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 84: UK GDP Per Capita, 2015-2020, $
    • Table 85: UK G-CSF Market, Population By Age Group, 2015-2023, Thousands
    • Table 86: UK, Per Capita Healthcare Expenditure, 2015-2019, $
    • Table 87: UK Estimated Average Expenditure, Cancer Prevalence, 2019
    • Table 88: UK G-CSF Market, Healthcare Services Market Size, By Country, 2015-2025, $ Billion
    • Table 89: UK G-CSF (Granulocyte Colony Stimulating Factors) Market, Historic, 2015 – 2020, $ Million
    • Table 90: UK G-CSF (Granulocyte Colony Stimulating Factors) Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 91: UK G-CSF (Granulocyte Colony Stimulating Factors) Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 92: UK G-CSF (Granulocyte Colony Stimulating Factors) Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 93: UK G-CSF (Granulocyte Colony Stimulating Factors) Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 94: UK G-CSF (Granulocyte Colony Stimulating Factors) Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 95: Germany G-CSF (Granulocyte Colony Stimulating Factors) Market, Historic, 2015 – 2020, $ Million
    • Table 96: Germany G-CSF (Granulocyte Colony Stimulating Factors) Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 97: Germany G-CSF (Granulocyte Colony Stimulating Factors) Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 98: Germany G-CSF (Granulocyte Colony Stimulating Factors) Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 99: Germany G-CSF (Granulocyte Colony Stimulating Factors) Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 100: Germany G-CSF (Granulocyte Colony Stimulating Factors) Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 101: France G-CSF (Granulocyte Colony Stimulating Factors) Market, Historic, 2015 – 2020, $ Million
    • Table 102: France G-CSF (Granulocyte Colony Stimulating Factors) Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 103: France G-CSF (Granulocyte Colony Stimulating Factors) Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 104: France G-CSF (Granulocyte Colony Stimulating Factors) Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 105: France G-CSF (Granulocyte Colony Stimulating Factors) Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 106: France G-CSF (Granulocyte Colony Stimulating Factors) Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 107: Eastern Europe GDP Per Capita, 2015-2020, $
    • Table 108: Eastern Europe G-CSF Market, Population By Age Group, By Country, 2015-2023, Thousands
    • Table 109: Eastern Europe, Per Capita Healthcare Expenditure, By Country, 2015-2019, $
    • Table 110: Eastern Europe Estimated Average Expenditure, Cancer Prevalence, 2019
    • Table 111: Eastern Europe G-CSF Market, Healthcare Services Market Size, By Country, 2015-2025, $ Billion
    • Table 112: Eastern Europe G-CSF (Granulocyte Colony Stimulating Factors) Market, Historic, 2015 – 2020, $ Million
    • Table 113: Eastern Europe G-CSF (Granulocyte Colony Stimulating Factors) Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 114: Eastern Europe G-CSF (Granulocyte Colony Stimulating Factors) Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 115: Eastern Europe G-CSF (Granulocyte Colony Stimulating Factors) Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 116: Eastern Europe G-CSF (Granulocyte Colony Stimulating Factors) Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 117: Eastern Europe G-CSF (Granulocyte Colony Stimulating Factors) Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 118: Russia G-CSF (Granulocyte Colony Stimulating Factors) Market, Historic, 2015 – 2020, $ Million
    • Table 119: Russia G-CSF (Granulocyte Colony Stimulating Factors) Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 120: Russia G-CSF (Granulocyte Colony Stimulating Factors) Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 121: Russia G-CSF (Granulocyte Colony Stimulating Factors) Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 122: Russia G-CSF (Granulocyte Colony Stimulating Factors) Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 123: Russia G-CSF (Granulocyte Colony Stimulating Factors) Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 124: North America GDP Per Capita, 2015-2020, $
    • Table 125: North America G-CSF Market, Population By Age Group, By Country, 2015-2023, Thousands
    • Table 126: North America, Per Capita Healthcare Expenditure, By Country, 2015-2019, $
    • Table 127: North America Estimated Average Expenditure, Cancer Prevalence, 2019
    • Table 128: North America G-CSF Market, Healthcare Services Market Size, By Country, 2015-2025, $ Billion
    • Table 129: North America G-CSF (Granulocyte Colony Stimulating Factors) Market, Historic, 2015 – 2020, $ Million
    • Table 130: North America G-CSF (Granulocyte Colony Stimulating Factors) Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 131: North America G-CSF (Granulocyte Colony Stimulating Factors) Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 132: North America G-CSF (Granulocyte Colony Stimulating Factors) Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 133: North America G-CSF (Granulocyte Colony Stimulating Factors) Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 134: North America G-CSF (Granulocyte Colony Stimulating Factors) Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 135: USA GDP Per Capita, 2015-2020, $
    • Table 136: USA G-CSF Market, Population By Age Group, 2015-2023, Thousands
    • Table 137: USA, Per Capita Healthcare Expenditure, 2015-2019, $
    • Table 138: USA Estimated Average Expenditure, Cancer Prevalence, 2019
    • Table 139: USA G-CSF Market, Healthcare Services Market Size, By Country, 2015-2025, $ Billion
    • Table 140: USA G-CSF (Granulocyte Colony Stimulating Factors) Market, Historic, 2015 – 2020, $ Million
    • Table 141: USA G-CSF (Granulocyte Colony Stimulating Factors) Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 142: USA G-CSF (Granulocyte Colony Stimulating Factors) Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 143: USA G-CSF (Granulocyte Colony Stimulating Factors) Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 144: USA G-CSF (Granulocyte Colony Stimulating Factors) Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 145: USA G-CSF (Granulocyte Colony Stimulating Factors) Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 146: South America GDP Per Capita, 2015-2020, $
    • Table 147: South America G-CSF Market, Population By Age Group, By Country, 2015-2023, Thousands
    • Table 148: South America, Per Capita Healthcare Expenditure, By Country, 2015-2019, $
    • Table 149: South America Estimated Average Expenditure, Cancer Prevalence, 2019
    • Table 150: South America G-CSF Market, Healthcare Services Market Size, By Country, 2015-2025, $ Billion
    • Table 151: South America G-CSF (Granulocyte Colony Stimulating Factors) Market, Historic, 2015 – 2020, $ Million
    • Table 152: South America G-CSF (Granulocyte Colony Stimulating Factors) Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 153: South America G-CSF (Granulocyte Colony Stimulating Factors) Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 154: South America G-CSF (Granulocyte Colony Stimulating Factors) Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 155: South America G-CSF (Granulocyte Colony Stimulating Factors) Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 156: South America G-CSF (Granulocyte Colony Stimulating Factors) Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 157: Brazil G-CSF (Granulocyte Colony Stimulating Factors) Market, Historic, 2015 – 2020, $ Million
    • Table 158: Brazil G-CSF (Granulocyte Colony Stimulating Factors) Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 159: Brazil G-CSF (Granulocyte Colony Stimulating Factors) Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 160: Brazil G-CSF (Granulocyte Colony Stimulating Factors) Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 161: Brazil G-CSF (Granulocyte Colony Stimulating Factors) Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 162: Brazil G-CSF (Granulocyte Colony Stimulating Factors) Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 163: Middle East GDP Per Capita, 2015-2020, $
    • Table 164: Middle East G-CSF Market, Population By Age Group, By Country, 2015-2023, Thousands
    • Table 165: Middle East, Per Capita Healthcare Expenditure, By Country, 2015-2019, $
    • Table 166: Middle East G-CSF Market, Healthcare Services Market Size, By Country, 2015-2025, $ Billion
    • Table 167: Middle East G-CSF (Granulocyte Colony Stimulating Factors) Market, Historic, 2015 – 2020, $ Million
    • Table 168: Middle East G-CSF (Granulocyte Colony Stimulating Factors) Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 169: Middle East G-CSF (Granulocyte Colony Stimulating Factors) Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 170: Middle East G-CSF (Granulocyte Colony Stimulating Factors) Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 171: Middle East G-CSF (Granulocyte Colony Stimulating Factors) Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 172: Middle East G-CSF (Granulocyte Colony Stimulating Factors) Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 173: Africa GDP Per Capita, 2015-2020, $
    • Table 174: Africa G-CSF Market, Population By Age Group, By Country, 2015-2023, Thousands
    • Table 175: Africa, Per Capita Healthcare Expenditure, By Country, 2015-2019, $
    • Table 176: Africa G-CSF Market, Healthcare Services Market Size, By Country, 2015-2025, $ Billion
    • Table 177: Africa G-CSF (Granulocyte Colony Stimulating Factors) Market, Historic, 2015 – 2020, $ Million
    • Table 178: Africa G-CSF (Granulocyte Colony Stimulating Factors) Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 179: Africa G-CSF (Granulocyte Colony Stimulating Factors) Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 180: Africa G-CSF (Granulocyte Colony Stimulating Factors) Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 181: Africa G-CSF (Granulocyte Colony Stimulating Factors) Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 182: Africa G-CSF (Granulocyte Colony Stimulating Factors) Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 183: Global G- CSF Market, Key Competitor Estimated Market Shares, 2019, Percentage (%)
    • Table 184: Amgen Inc.– Financial Performance, 2015 – 2019, $ Billion
    • Table 185: Sandoz (Novartis) – Financial Performance, 2015 – 2019, $ Billion
    • Table 186: Biocon – Financial Performance, 2015 – 2019, $ Billion
    • Table 187: Mylan – Financial Performance, 2015 – 2019, $ Billion
    • Table 188: Teva Pharmaceuticals – Financial Performance, 2015 – 2019, $ Billion
    • Table 189: Global G-CSF (Granulocyte Colony Stimulating Factors) Market Size Gain ($ Million), 2020 – 2025, By Country
    • Table 190: Global G-CSF (Granulocyte Colony Stimulating Factors) Market Size Gain ($ Million), Segmentation By Type, 2020 – 2025
    • Table 191: Global G-CSF (Granulocyte Colony Stimulating Factors) Market Size Gain ($ Million), Segmentation By Application, 2020 – 2025
    • Table 192: CSF (Granulocyte Colony Stimulating Factors) Market - Data Sources

    List Of Figures

      Figure 1: Global Functional Foods Market Segmentation By Product Type
    • Figure 2: Global Functional Foods Market Segmentation By Application
    • Figure 3: Global Functional Foods Market Segmentation By Ingredient
    • Figure 4: Global Functional Food Market, Historic, 2015 – 2020, $ Million
    • Figure 5: Global Functional Food Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 6: Global Functional Food Market, Segmentation By Product Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 7: Global Functional Food Market, Segmentation By Ingredients, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 8: Global Functional Food Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 9: Global Functional Food Market, By Region, Historic and Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 10: Global Functional Food Market, By Country, Historic and Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 11: Asia-Pacific Functional Food Market, Historic, 2015 – 2020, $ Million
    • Figure 12: Asia-Pacific Functional Food Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 13: Asia-Pacific Functional Food Market, Segmentation By Product Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 14: Asia-Pacific Functional Food Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 15: China Functional Food Market, Historic, 2015 – 2020, $ Million
    • Figure 16: China Functional Food Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 17: China Functional Food Market, Segmentation By Product Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 18: China Functional Food Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 19: India Functional Food Market, Historic, 2015 – 2020, $ Million
    • Figure 20: India Functional Food Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 21: India Functional Food Market, Segmentation By Product Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 22: India Functional Food Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 23: Japan Functional Food Market, Historic, 2015 – 2020, $ Million
    • Figure 24: Japan Functional Food Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 25: Japan Functional Food Market, Segmentation By Product Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 26: Japan Functional Food Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 27: Australia Functional Food Market, Historic, 2015 – 2020, $ Million
    • Figure 28: Australia Functional Food Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 29: Australia Functional Food Market, Segmentation By Product Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 30: Australia Functional Food Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 31: Indonesia Functional Food Market, Historic, 2015 – 2020, $ Million
    • Figure 32: Indonesia Functional Food Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 33: Indonesia Functional Food Market, Segmentation By Product Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 34: Indonesia Functional Food Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 35: South Korea Functional Food Market, Historic, 2015 – 2020, $ Million
    • Figure 36: South Korea Functional Food Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 37: South Korea Functional Food Market, Segmentation By Product Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 38: South Korea Functional Food Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 39: Western Europe Functional Food Market, Historic, 2015 – 2020, $ Million
    • Figure 40: Western Europe Functional Food Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 41: Western Europe Functional Food Market, Segmentation By Product Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 42: Western Europe Functional Food Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 43: UK Functional Food Market, Historic, 2015 – 2020, $ Million
    • Figure 44: UK Functional Food Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 45: UK Functional Food Market, Segmentation By Product Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 46: UK Functional Food Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 47: Germany Functional Food Market, Historic, 2015 – 2020, $ Million
    • Figure 48: Germany Functional Food Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 49: Germany Functional Food Market, Segmentation By Product Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 50: Germany Functional Food Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 51: France Functional Food Market, Historic, 2015 – 2020, $ Million
    • Figure 52: France Functional Food Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 53: France Functional Food Market, Segmentation By Product Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 54: France Functional Food Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 55: Eastern Europe Functional Food Market, Historic, 2015 – 2020, $ Million
    • Figure 56: Eastern Europe Functional Food Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 57: Eastern Europe Functional Food Market, Segmentation By Product Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 58: Eastern Europe Functional Food Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 59: Russia Functional Food Market, Historic, 2015 – 2020, $ Million
    • Figure 60: Russia Functional Food Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 61: Russia Functional Food Market, Segmentation By Product Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 62: Russia Functional Food Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 63: North America Functional Food Market, Historic, 2015 – 2020, $ Million
    • Figure 64: North America Functional Food Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 65: North America Functional Food Market, Segmentation By Product Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 66: North America Functional Food Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 67: USA Functional Food Market, Historic, 2015 – 2020, $ Million
    • Figure 68: USA Functional Food Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 69: USA Functional Food Market, Segmentation By Product Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 70: USA Functional Food Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 71: South America Functional Food Market, Historic, 2015 – 2020, $ Million
    • Figure 72: South America Functional Food Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 73: South America Functional Food Market, Segmentation By Product Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 74: South America Functional Food Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 75: Brazil Functional Food Market, Historic, 2015 – 2020, $ Million
    • Figure 76: Brazil Functional Food Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 77: Brazil Functional Food Market, Segmentation By Product Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 78: Brazil Functional Food Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 79: Middle East Functional Food Market, Historic, 2015 – 2020, $ Million
    • Figure 80: Middle East Functional Food Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 81: Middle East Functional Food Market, Segmentation By Product Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 82: Middle East Functional Food Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 83: Africa Functional Food Market, Historic, 2015 – 2020, $ Million
    • Figure 84: Africa Functional Food Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 85: Africa Functional Food Market, Segmentation By Product Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 86: Africa Functional Food Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 87: Global Functional Food, Key Competitor Estimated Market Shares, 2019, Percentage (%)
    • Figure 88: Nestle S.A. – Financial Performance, 2015 – 2020, $ Billion
    • Figure 89: Danone – Financial Performance, 2015-2019, $ Billion
    • Figure 90: PepsiCo, Inc. – Financial Performance, 2015 – 2020, $ Billion
    • Figure 91: Kellogg’s – Financial Performance, 2015 – 2019, $ Billion
    • Figure 92: Arla Foods – Financial Performance, 2015 – 2019, $ Billion

    The Business Research Company offers the plasma fractionation market research report 2022 with industry size, share, segments and market growth

    Read More

    Latest Cell Therapy Market Growth Study 2022-2026 By The Business Research Company

    Read More

    Global Gene Therapy Market 2022 – Market Opportunities And Strategies

    Read More

    The Microbiome Market Share, Market Size, And Growth Rate 2022

    Read More

    Latest TNF Alpha Inhibitors Market Growth Study 2022-2026 By The Business Research Company

    Read More

    The Business Research Company offers the nucleic acid based gene therapy market research report 2022 with industry size, share, segments and market growth

    Read More

    The Business Research Company offers the radiopharmaceuticals market research report 2022 with industry size, share, segments and market growth

    Read More

    The Business Research Company offers the pegfilgrastim biosimilars market market research report 2022 with industry size, share, segments and market growth

    Read More

    Vascular Endothelial Growth Factor (VEGF) Inhibitor Global Market Report 2024 – By Drugs Type (Avastin, Tecentriq, Lucentis, Tagrisso, Cometriq, Eylea, Other Drug Types), By Route Of Administration (Oral, Intravenous, Intravitreal), By Application (Oncology, Ophthalmology, Other Applications) – Market Size, Trends, And Global Forecast 2024-2033

    View Report

    Checkpoint Inhibitors Global Market Report 2024 – By Drug (PD-1 Inhibitors, PD-L1 Inhibitors, CTLA-4, Chimeric Antigen Receptor T-cell, Other Drugs), By Application (Lung Cancer, Renal Cancer, Blood Cancer, Bladder Cancer, Melanoma, Other Applications), By End-Users (Hospitals Pharmacies, Retail Pharmacies, Online Pharmacies) – Market Size, Trends, And Global Forecast 2024-2033

    View Report

    TNF Alpha Inhibitors Global Market Report 2024 – By Drug (Remicade (Infliximab), Enbrel (Etanercept), Humira (Adalimumab), Cimzia (Certolizumab Pegol), Simponi (Golimumab)), By Route Of Administration (Oral, Subcutaneous, Intravenous, Other Route Of Administration), By Disease Type (Inflammatory Bowel Disease, Psoriatic Arthritis, Ulcerative Colitis (UC), Rheumatoid Arthritis, Ankylosing Spondylitis, Other Disease Types) – Market Size, Trends, And Global Forecast 2024-2033

    View Report

    Protein Inhibitors Global Market Report 2024 – By Product (Protein Kinase Inhibitors, Monoclonal Antibody, Other Products), By Application (Oncology, Inflammatory Diseases, Other Applications), By Distribution Channel (Hospital Pharmacies, Independent Pharmacies, Online Pharmacies ) – Market Size, Trends, And Global Forecast 2024-2033

    View Report

    HER2 Inhibitors Global Market Report 2024 – By Treatment (Monotherapy, Combination Therapy), By Application (Squamous Cell Carcinoma, Adenocarcinoma, Large Cell Carcinoma, Breast Cancer, Other Applications), By End User (Hospitals, Clinics, Other End Users) – Market Size, Trends, And Global Forecast 2024-2033

    View Report

    Interleukin Inhibitors Global Market Report 2024 – By Type (IL-17, IL-23, IL-1, IL-5, IL-6, Other Types), By Application (Psoriasis, Psoriatic Arthritis, Rheumatoid Arthritis, Asthma, Inflammatory Bowel Disease, Other Applications), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) – Market Size, Trends, And Global Forecast 2024-2033

    View Report

    Immunosuppressants Global Market Report 2024 – By Drug Class (Corticosteroids, Monoclonal Antibodies (mAbs), Calcineurin Inhibitors, mTOR Inhibitors, Anti-Proliferative Agents, Other Drug Classes), By Indication (Organ Transplantation, Autoimmune Disorders, Non-Autoimmune Inflammatory Diseases), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) – Market Size, Trends, And Global Forecast 2024-2033

    View Report

    Nucleic Acid Based Gene Therapy Global Market Report 2024 – By Technology (Anti-Sence and Anti-Gene, Short Inhibitory Sequences, Gene Transfer Therapy, Nucleoside Analogs, Ribozymes, Aptamers, Other Technologies), By Application (Oncology, Muscular Dystrophy/ Muscular Disorders, Rare Diseases), By End User (Hospitals And Clinics, Academic And Research Institutes) – Market Size, Trends, And Global Forecast 2024-2033

    View Report

    Frequently Asked Questions

    What is the definition of the G-CSF (granulocyte colony stimulating factors) market?

    G-CSF (granulocyte colony stimulating factors) refers to a type of colony-stimulating factor that aids in the bone marrow's ability to produce more white blood cells. Patients who have specific tumours, neutropenia brought on by some types of chemotherapy, or severe persistent neutropenia unrelated to cancer treatment are all treated with G-CSF. Filgrastim and Granulocyte Colony-Stimulating Factor are other names for it. For further insights on the G-CSF (granulocyte colony stimulating factors) market, request a sample here

    How will the G-CSF (granulocyte colony stimulating factors) market drivers and restraints affect the G-CSF (granulocyte colony stimulating factors) market dynamics? What forces will shape the G-CSF (granulocyte colony stimulating factors) industry going f

    The G-CSF (granulocyte colony stimulating factors) market growth is aided by increasing prevalence of cancer. However, some G-CSF (granulocyte colony stimulating factors) market restraints include high cost. For further insights on the G-CSF (granulocyte colony stimulating factors) market, request a sample here

    What is the forecast market size or the forecast market value of the G-CSF (granulocyte colony stimulating factors) market?

    The G-CSF (granulocyte colony stimulating factors) market is expected to reach $9.94 billion in 2027 at a rate of 4.2%. For further insights on the G-CSF (granulocyte colony stimulating factors) market, request a sample here

    How is the G-CSF (granulocyte colony stimulating factors) market segmented?

    The global G-CSF (granulocyte colony stimulating factors) market is segmented as
    1) By Type: Lenograstim (Granocyte), Filgrastim (Neupogen, Zarzio, Nivestim, Accofil), Long Acting (Pegylated) Filgrastim (Pegfilgrastim, Neulasta, Pelmeg, Ziextenco), Lipegfilgrastim (Lonquex)
    2) By Application: Oncological Diseases, Blood Disorders, Growth Hormone Deficiencies, Chronic And Autoimmune Disorders, Other Applications
    3) By Product: Tablet, Capsule, Other Products
    For further insights on the G-CSF (granulocyte colony stimulating factors) market,     request a sample here

    Which region has the largest share of the G-CSF (granulocyte colony stimulating factors) market? What are the largest region's market size and growth rate?

    North America was the largest region in the G-CSF (granulocyte colony stimulating factors) market in 2022. For detailed insights on the largest region's market size and growth rate, request a sample here.

    Who are the major players in the G-CSF (granulocyte colony stimulating factors) market?

    Key competitors in the G-CSF (granulocyte colony stimulating factors) market are, BioCad, Teva Pharmaceuticals, Pfizer, Intas Pharmaceuticals, Novartis AG, Stada Arzneimittel, Dong-A Socio Group, Amgen, Dr. Reddy's Laboratories, Celltrion Inc., Emcure Pharmaceuticals. For further insights on the G-CSF (granulocyte colony stimulating factors) market, request a sample here.

    What are the key trends in the G-CSF (granulocyte colony stimulating factors) market?

    Major trends influencing the G-CSF (granulocyte colony stimulating factors) market include focusing on strategic collaborations for developing innovative products and increasing market share. While companies have long collaborated with each other as well as with academic and research institutions in this market by way of partnerships, in or out-licensing deals, has been increasing over recent years. For further insights on the G-CSF (granulocyte colony stimulating factors) market, request a sample here.

    What are the major opportunities in the G-CSF (granulocyte colony stimulating factors) market? What are the strategies for the G-CSF (granulocyte colony stimulating factors) market?

    For detailed insights on the major opportunities and strategies in the G-CSF (granulocyte colony stimulating factors) market, request a sample here.

    How does the G-CSF (granulocyte colony stimulating factors) market relate to the overall economy and other similar markets?

    For detailed insights on G-CSF (granulocyte colony stimulating factors) market's relation to the overall economy and other similar markets, request a sample here.

    What are the latest mergers and acquisitions in the G-CSF (granulocyte colony stimulating factors) industry?

    For detailed insights on the mergers and acquisitions in the G-CSF (granulocyte colony stimulating factors) industry, request a sample here.

    What are the key dynamics influencing the G-CSF (granulocyte colony stimulating factors) market growth? SWOT analysis of the G-CSF (granulocyte colony stimulating factors) market.

    For detailed insights on the key dynamics influencing the G-CSF (granulocyte colony stimulating factors) market growth and SWOT analysis of the G-CSF (granulocyte colony stimulating factors) industry, request a sample here.